1
|
Yang WC, Chang YJ, Lin YC, Chen CY, Peng YC, Wu HP. Survey of nil per os duration of patients admitted to the emergency department due to vomiting. Medicine (Baltimore) 2019; 98:e15087. [PMID: 30946363 PMCID: PMC6456003 DOI: 10.1097/md.0000000000015087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
During the acute phase of vomiting, even a small amount of water may not be tolerated by mouth. Early refeeding may cause re-vomiting in patients, whereas late refeeding may result in dehydration and hypoglycemia. Nil per os (NPO) may be generally recommended by primary physicians, but the appropriate NPO duration for these patients is still unclear.The study aimed to identify the ideal NPO duration for patients with acute vomiting.We prospectively recruited patients with vomiting who underwent NPO management and were administered antiemetic agents in the emergency department (ED) and the pediatric ED. The demographics, final diagnosis, clinical manifestations, medical management, NPO duration, and laboratory data were collected and analyzed to identify the ideal NPO durationA total of 304 patients with vomiting who were admitted in the ED were enrolled. The major diagnosis was acute gastroenteritis (AGE) (82.9%), followed by acute gastritis and colitis. Most patients were younger than 6 years (43.8%). Apart from abdominal pain and vomiting, nausea was the most common symptom (93.1%). NPO duration of 4 to 6 hours had the lowest rate of refeeding failure (3.7%) compared to the other NPO durations.For patients with acute vomiting who are admitted to the ED, NPO duration of 4 to 6 hours may be necessary and should be recommended by primary ED physicians.
Collapse
Affiliation(s)
- Wen-Chieh Yang
- Department of Pediatric Emergency China Medical University Children's Hospital, China Medical University
- Department of Medicine, College of Medicine, China Medical University
| | - Yu-Jun Chang
- Laboratory of Epidemiology and Biostastics, Changhua Christian Hospital
| | - Ya-Chun Lin
- Department of Nursing, Changhua Christian Hospital, Changhua
| | - Chun-Yu Chen
- Department of Pediatric Emergency China Medical University Children's Hospital, China Medical University
- Department of Medicine, College of Medicine, China Medical University
| | - Yi-Chin Peng
- Department of Pediatric Emergency China Medical University Children's Hospital, China Medical University
- Department of Medicine, College of Medicine, China Medical University
| | - Han-Ping Wu
- Department of Pediatric Emergency China Medical University Children's Hospital, China Medical University
- Department of Medicine, College of Medicine, China Medical University
- Department of Medical Research, China Medical University Children's Hospital, China Medical University, Taichung, Taiwan
| |
Collapse
|
2
|
Rudd JA, Chan SW, Ngan MP, Tu L, Lu Z, Giuliano C, Lovati E, Pietra C. Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT 3 Antagonist, Palonosetron and With the NK 1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew). Front Pharmacol 2018; 9:869. [PMID: 30127745 PMCID: PMC6087754 DOI: 10.3389/fphar.2018.00869] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2018] [Accepted: 07/18/2018] [Indexed: 11/22/2022] Open
Abstract
Ghrelin has well-known activity to stimulate appetite and weight gain. Evidence suggests that ghrelin may also have effects in reducing chemotherapy-induced emesis via growth hormone secretagogue receptors (GHS-R1A) in the brain. However, it is not known whether the stimulation of GHS-R1A has broad inhibitory anti-emetic effects. In the present studies, we used Suncus murinus to investigate the potential of the new and novel orally bioavailable brain-penetrating GHS-R1A mimetic, HM01 (1-[(1S)-1-(2,3-dichloro-4-methoxyphenyl)ethyl]-3-methyl-3-[(4R)-1-Methyl-3,3-dimethyl-4-piperidyl]urea), to reduce emesis induced by a variety of emetic challenges. HM01 (1 to 30 mg/kg, p.o.) antagonized emesis induced by cisplatin (30 mg/kg, i.p.) and by motion (4 cm horizontal displacement, 1 Hz) but was ineffective against emesis induced by nicotine (5 mg/kg, s.c.) and copper sulfate (120 mg/kg by intragastric gavage). In other experiments, HM01 (3 mg/kg, p.o.) enhanced the anti-emetic control of a regimen of palonosetron (0.01 mg/kg, p.o.) alone and palonosetron (0.01 mg/kg p.o.) plus netupitant (1 mg/kg, p.o.). HM01 (10 mg/kg, p.o.) also had positive effects in increasing feeding and drinking in nicotine-treated animals, and it shortened the latency to drink in animals treated with cisplatin. These data indicate that brain-penetrating GHS-R1A agonists may have use alone and/or in combination with standard anti-emetic regimens for the treatment of chemotherapy-induced nausea and vomiting and motion sickness.
Collapse
Affiliation(s)
- John A Rudd
- Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.,Brain and Mind Institute, The Chinese University of Hong Kong, Shatin, Hong Kong
| | - Sze W Chan
- School of Health Sciences, Caritas Institute of Higher Education, Tseung Kwan O New Town, Hong Kong
| | - Man P Ngan
- Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
| | - Longlong Tu
- Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
| | - Zengbing Lu
- Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
| | - Claudio Giuliano
- Helsinn Healthcare SA, Research and Development, Lugano, Switzerland
| | - Emanuela Lovati
- Helsinn Healthcare SA, Research and Development, Lugano, Switzerland
| | - Claudio Pietra
- Helsinn Healthcare SA, Research and Development, Lugano, Switzerland
| |
Collapse
|
3
|
Eiseman JL, Sciullo M, Wang H, Beumer JH, Horn CC. Estimation of body surface area in the musk shrew ( Suncus murinus): a small animal for testing chemotherapy-induced emesis. Lab Anim 2017; 51:534-537. [PMID: 28948895 DOI: 10.1177/0023677217695851] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Several cancer chemotherapies cause nausea and vomiting, which can be dose-limiting. Musk shrews are used as preclinical models for chemotherapy-induced emesis and for antiemetic effectiveness. Unlike rats and mice, shrews possess a vomiting reflex and demonstrate an emetic profile similar to humans, including acute and delayed phases. As with most animals, dosing of shrews is based on body weight, while translation of such doses to clinically equivalent exposure requires doses based on body surface area. In the current study body surface area in musk shrews was directly assessed to determine the Meeh constant (Km) conversion factor (female = 9.97, male = 9.10), allowing estimation of body surface area based on body weight. These parameters can be used to determine dosing strategies for shrew studies that model human drug exposures, particularly for investigating the emetic liability of cancer chemotherapeutic agents.
Collapse
Affiliation(s)
- Julie L Eiseman
- 1 Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, USA.,2 Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, USA
| | - Michael Sciullo
- 3 Biobehavioral Oncology Program, University of Pittsburgh Cancer Institute, Pittsburgh, USA
| | - Hong Wang
- 4 Department of Biostatistics, University of Pittsburgh, Pittsburgh, USA
| | - Jan H Beumer
- 1 Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, USA.,5 Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, USA.,6 Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, USA
| | - Charles C Horn
- 3 Biobehavioral Oncology Program, University of Pittsburgh Cancer Institute, Pittsburgh, USA.,7 Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, USA.,8 Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, USA.,9 Center for Neuroscience, University of Pittsburgh, Pittsburgh, USA
| |
Collapse
|
4
|
Horn C, Zirpel L, Sciullo M, Rosenberg D. Impact of electrical stimulation of the stomach on gastric distension-induced emesis in the musk shrew. Neurogastroenterol Motil 2016; 28:1217-32. [PMID: 27072787 PMCID: PMC4956516 DOI: 10.1111/nmo.12821] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2015] [Accepted: 02/19/2016] [Indexed: 01/11/2023]
Abstract
BACKGROUND Gastric electrical stimulation (GES) is implicated as a potential therapy for difficult-to-treat nausea and vomiting; however, there is a lack of insight into the mechanisms responsible for these effects. This study tested the relationship between acute GES and emesis in musk shrews, an established emetic model system. METHODS Urethane-anesthetized shrews were used to record emetic responses (monitoring intra-tracheal pressure and esophageal contractions), respiration rate, heart rate variability, blood pressure, and gastrointestinal electromyograms. We investigated the effects of acute GES pulse duration (0.3, 1, 5, and 10 ms), current amplitude (0.5, 1, and 2 mA), pulse frequency (8, 15, 30, and 60 Hz), and electrode placement (antrum, body, and fundus) on emesis induced by gastric stretch, using a balloon. KEY RESULTS There were four outcomes: (i) GES did not modify the effects of gastric stretch-induced emesis; (ii) GES produced emesis, depending on the stimulation parameters, but was less effective than gastric stretch; (iii) other physiological changes were closely associated with emesis and could be related to a sub-threshold activation of the emetic system, including suppression of breathing and rise in blood pressure; and (iv) a control experiment showed that 8-OH-DPAT, a reported 5-HT1A receptor agonist that acts centrally as an antiemetic, blocked gastric stretch-induced emesis. CONCLUSIONS AND INFERENCES These results do not support an antiemetic effect of acute GES on gastric distension-induced emesis within the range of conditions tested, but further evaluation should focus on a broader range of emetic stimuli and GES stimulation parameters.
Collapse
Affiliation(s)
- C.C. Horn
- Biobehavioral Oncology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA,Department of Medicine: Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA,Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA,Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA,Corresponding Author: Charles C. Horn, PhD, Hillman Cancer Center – Research Pavilion, G.17b, 5117 Centre Avenue, Pittsburgh, PA 15213, Phone: (+00) 1-412-623-1417, Fax: 412-623-1119,
| | - L. Zirpel
- Neuromodulation Global Research, Medtronic
| | - M. Sciullo
- Biobehavioral Oncology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
| | - D. Rosenberg
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|
5
|
Horn CC, Meyers K, Oberlies N. Musk shrews selectively bred for motion sickness display increased anesthesia-induced vomiting. Physiol Behav 2013; 124:129-37. [PMID: 24239993 DOI: 10.1016/j.physbeh.2013.11.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2013] [Accepted: 11/06/2013] [Indexed: 10/26/2022]
Abstract
Susceptibility to motion sickness is a predictor of postoperative nausea and vomiting, and studies in humans suggest that genetic factors determine sensitivity to motion sickness. The aim of the current study was to determine if a preclinical model could be selectively bred for motion-induced emesis and to assess a potential relationship to anesthesia-induced emesis. Musk shrews were tested for motion-induced emesis using a shaker plate (10min, 1Hz, and 4cm of lateral displacement). Animals were rank ordered for motion-induced emesis and selectively bred to produce high and low response strains. Shrews were also tested with nicotine (5mg/kg, sc), copper sulfate (CuSO4; 120mg/kg, ig), and isoflurane anesthesia (10min; 3%) to measure responses to a panel of emetic stimuli. High response strain shrews demonstrated significantly more emetic episodes to motion exposure compared to low response strain animals in the F1 and F2 generations. In F2 animals, there were no significant differences in total emetic responses or emetic latency between strains after nicotine injection or CuSO4 gavage. However, isoflurane exposure stimulated more emesis in F1 and F2 high versus low strain animals, which suggests a relationship between vestibular- and inhalational anesthesia-induced emesis. Overall, these results indicate genetic determinants of motion sickness in a preclinical model and a potential common mechanism for motion sickness and inhalational anesthesia-induced emesis. Future work may include genetic mapping of potential "emetic sensitivity genes" to develop novel therapies or diagnostics for patients with high risk of nausea and vomiting.
Collapse
Affiliation(s)
- Charles C Horn
- Biobehavioral Medicine in Oncology Program, Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA, USA; Dept. of Medicine, Div. of Gastroenterology, Hepatology, and Nutrition, Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Dept. of Anesthesiology, Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Neuroscience, Univ. of Pittsburgh, Pittsburgh, PA, USA.
| | | | | |
Collapse
|
6
|
Dudley ES, Grunden BK, Crocker C, Boivin GP. Incidence of dental lesions in musk shrews (Suncus murinus) and their association with sex, age, body weight and diet. Lab Anim (NY) 2013; 42:422-6. [PMID: 24150169 DOI: 10.1038/laban.408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2013] [Accepted: 09/10/2013] [Indexed: 11/09/2022]
Abstract
Both wild and laboratory strains of the musk shrew (Suncus murinus) have a high incidence of periodontitis. The authors completed necropsy examinations in 51 shrews to identify dental lesions including tooth loss, mobility and fractures. Dental lesions were identified in significantly more females than males, and older animals were more likely to have lesions present. Shrews with one or more dental lesions weighed significantly less than those without lesions present. Dietary supplementation with mealworms did not significantly affect the incidence of dental lesions or the body weight of male or female shrews. The authors recommend routine body weight measurement as a simple, noninvasive method of detecting shrews with an increased likelihood of having dental lesions.
Collapse
Affiliation(s)
- Emily S Dudley
- Laboratory Animal Resources, Wright State University, Dayton, OH
| | | | | | | |
Collapse
|
7
|
Horn CC, Wang H, Estival L, Meyers K, Magnusson MS. Novel dynamic measures of emetic behavior in musk shrews. Auton Neurosci 2013; 179:60-7. [PMID: 23953843 DOI: 10.1016/j.autneu.2013.07.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Revised: 07/13/2013] [Accepted: 07/18/2013] [Indexed: 11/29/2022]
Abstract
The emetic reflex occurs as a pattern of motor responses produced by a network of neurons in the hindbrain. Despite an understanding of the sequence of motor outputs that form an emetic episode (EE), the variability in the dynamics of multiple EEs across time remains a mystery. Many clinical investigations rely on once a day patient recall of total amount of vomiting, and preclinical studies frequently report only the total number of EE per unit time. The aim of the current study was to develop novel temporal measures of emetic activation in a preclinical model. Male and female musk shrews were tested with prototypical emetic stimuli: motion exposure (1 Hz), nicotine (5 mg/kg, sc), and copper sulfate (120 mg/kg, ig). New emetic measures included duration (time from first to last episode), rate, standard deviation of the inter-episode interval (SD-I), and a survival analysis of emetic latency (analyzed with Cox regression). Behavioral patterns associated with emesis were also assessed using statistical temporal pattern (T-pattern) analysis to measure nausea-like behaviors (e.g., immobility). The emetic stimuli produced different levels of total EE number, duration, rate, and SD-I. A typical antiemetic, the neurokinin 1 receptor antagonist CP-99,994, suppressed the number of EEs but was less effective for reducing the duration or prolonging the emetic latency. Overall, the current study shows the use of novel dynamic behavioral measures to more comprehensively assess emesis and the impact of therapies.
Collapse
Affiliation(s)
- Charles C Horn
- Biobehavioral Medicine in Oncology Program, Univ. Pittsburgh Cancer Institute, Pittsburgh, PA, USA; Dept. Medicine: Div. Gastroenterology, Hepatology, and Nutrition, Univ. Pittsburgh School of Medicine, Pittsburgh, PA, USA; Dept. Anesthesiology, Univ. Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Neuroscience, Univ. Pittsburgh, Pittsburgh, PA, USA.
| | | | | | | | | |
Collapse
|
8
|
Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews. Physiol Behav 2012; 106:562-8. [PMID: 22504494 DOI: 10.1016/j.physbeh.2012.03.031] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2012] [Revised: 02/28/2012] [Accepted: 03/28/2012] [Indexed: 11/20/2022]
Abstract
Although partially controlled with antiemetic drugs, postoperative nausea and vomiting (PONV) continues to be a problem for many patients. Clinical research suggests that opioid analgesics and volatile anesthetics are the main triggers of PONV. The aim of this study was to develop an animal model for post-anesthesia vomiting for future studies to further determine mechanisms and preclinical drug efficacy. Ferrets (N=34) were initially used because they have served as a gold standard for emesis research. Ferrets were tested with several doses of morphine, inhaled isoflurane, and a positive control injection of cisplatin (a chemotherapy agent) to induce emesis. Musk shrews (a small animal model; N=36) were also tested for emesis with isoflurane exposure. A control injection of cisplatin produced emesis in ferrets (ip, 129.8±22.0 retches; 13.7±2.3 vomits; mean±SEM). Morphine also produced a dose-response on emesis in ferrets, with maximal responses at 0.9 mg/kg (sc, 29.6±12.6 retches; 1.8±0.9, vomits). Isoflurane exposure (2-4% for 10 min to 6h exposure) failed to induce vomiting, was not associated with an increased frequency in emesis when combined with a low dose of morphine (0.1 mg/kg, sc), and failed to produce consistent effects on food and water intake. In contrast to ferrets, musk shrews were very sensitive to isoflurane-induced emesis (0.5 to 3%, 10 min exposure; up to 11.8±2.4 emetic episodes). Overall, these results indicate that ferrets will not be useful for delineating mechanisms responsible for isoflurane-induced emesis; however, musk shrews may prove to be a model for vomiting after inhalation of volatile agents.
Collapse
|
9
|
Horn CC, Henry S, Meyers K, Magnusson MS. Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews. Front Neurosci 2011; 5:88. [PMID: 21808604 PMCID: PMC3139242 DOI: 10.3389/fnins.2011.00088] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2011] [Accepted: 06/25/2011] [Indexed: 02/05/2023] Open
Abstract
Nausea and vomiting are common symptoms in patients with many diseases, including cancer and its treatments. Although the neurological basis of vomiting is reasonably well known, an understanding of the physiology of nausea is lacking. The primary barrier to mechanistic research on the nausea system is the lack of an animal model. Indeed investigating the effects of anti-nausea drugs in pre-clinical models is difficult because the primary readout is often emesis. It is known that animals show a behavioral profile of sickness, associated with reduced feeding and movement, and possibly these general measures are signs of nausea. Studies attempting to relate the occurrence of additional behaviors to emesis have produced mixed results. Here we applied a statistical method, temporal pattern (t-pattern) analysis, to determine patterns of behavior associated with emesis. Musk shrews were injected with the chemotherapy agent cisplatin (a gold standard in emesis research) to induce acute (<24 h) and delayed (>24 h) emesis. Emesis and other behaviors were coded and tracked from video files. T-pattern analysis revealed hundreds of non-random patterns of behavior associated with emesis, including sniffing, changes in body contraction, and locomotion. There was little evidence that locomotion was inhibited by the occurrence of emesis. Eating, drinking, and other larger body movements including rearing, grooming, and body rotation, were significantly less common in emesis-related behavioral patterns in real versus randomized data. These results lend preliminary evidence for the expression of emesis-related behavioral patterns, including reduced ingestive behavior, grooming, and exploratory behaviors. In summary, this statistical approach to behavioral analysis in a pre-clinical emesis research model could be used to assess the more global effects and limitations of drugs used to control nausea and its potential correlates, including reduced feeding and activity levels.
Collapse
Affiliation(s)
- Charles C Horn
- Biobehavioral Medicine in Oncology Program, University of Pittsburgh Cancer Institute Pittsburgh, PA, USA
| | | | | | | |
Collapse
|
10
|
Huang D, Meyers K, Henry S, De la Torre F, Horn CC. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew. J Neurosci Methods 2011; 197:249-58. [PMID: 21392533 DOI: 10.1016/j.jneumeth.2011.02.032] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2011] [Revised: 02/25/2011] [Accepted: 02/28/2011] [Indexed: 11/17/2022]
Abstract
Vomiting is a common side effect of cancer chemotherapy and many drug treatments and diseases. In animal studies, the measurement of vomiting usually requires direct observation, which is time consuming and often lacks temporal precision. Musk shrews have been used to study the neurobiology of emesis and have a rapid emetic episode (∼1 s for a sequence of retching and expulsion). The aim of the current study was to develop a method to automatically detect and characterize emetic episodes induced by the cancer chemotherapy agent cisplatin. The body contour in each video frame was tracked and normalized to a parameterized shape basis. The tracked shape was projected to a feature space that maximized the shape variations in the consecutive frames during retching. The resulting one dimensional projection was sufficient to detect most emetic episodes in the acute (peak at 2h) and delayed (peak at 54 h) phases after cisplatin treatment. Emetic episodes were relatively invariant in the number of retches (∼6.2), duration (∼1.2s), inter-retch interval (∼198 ms), and amplitude during the 72 h after cisplatin treatment. This approach should open a new vista into emesis research to permit tracking and analysis of emesis in a small animal model and facilitate the development of new antiemetic therapies. These results also yield a better understanding of the brain's central pattern generator for emesis and indicate that the retching response in the musk shrew (at ∼5.4 Hz) is the fastest ever recorded in a free-moving animal.
Collapse
Affiliation(s)
- Dong Huang
- Carnegie Mellon University, Robotics Institute, Pittsburgh, PA, USA
| | | | | | | | | |
Collapse
|
11
|
Schutt LK, Turner PV. Microchip-associated sarcoma in a shrew (Suncus murinus). JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE : JAALAS 2010; 49:638-641. [PMID: 20858367 PMCID: PMC2949435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/14/2009] [Revised: 01/20/2010] [Accepted: 02/03/2010] [Indexed: 05/29/2023]
Abstract
A 16-mo-old female house musk shrew (Suncus murinus) with a 1-wk history of a rapidly growing subcutaneous mass in the interscapsular region was euthanized and submitted for necropsy. Macroscopic examination identified an irregular, well-demarcated, solid, tan-white subcutaneous mass. A small cavity containing a microchip device was present at the center of the mass. In addition, massive splenomegaly was evident grossly. Histologically, the subcutaneous mass comprised spindle cells arranged in a storiform pattern of interweaving bundles, consistent with a high-grade soft tissue sarcoma with multifocal necrosis. Immunohistochemical investigation suggested that the neoplastic cells were positive for neuron-specific enolase and (rarely) α-smooth muscle actin and negative for cytokeratin, desmin, S100, and vimentin. In light of the mesenchymal histopathologic phenotype and the lack of specific immunoreactivity pattern, the mass was considered to be most consistent with a poorly differentiated sarcoma. To our knowledge, this is the first report of a microchip-associated soft tissue sarcoma in a shrew.
Collapse
|